NCT06887933 2025-03-21A Trial to Evaluate the Safety of Niraparib Tablets in Adult Female Participants With Advanced or Relapsed Epithelial Ovarian CancerGlaxoSmithKlinePhase 4 Not yet recruiting67 enrolled